Urgent.News

What's breaking now, across thousands of outlets.

Science

Sanofi to ‘rebuild trust’ with Regeneron; Apnimed adds to string of ‘upsized’ biotech IPOs

Sanofi wants to broaden the company’s productive partnership with Regeneron, its CEOs said. Elsewhere, Bristol Myers delayed two anticipated study readouts and a Shionogi-backed startup went public.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at biopharmadive.com →

More in Science

More from Friday 31 July →